Center Star Asset Management, LLC Astrazeneca PLC Transaction History

Center Star Asset Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 31, 2022	BUY	$53.02 - $135.75 $229,894 - $588,612	4,336 New	4,336 $238,000
Q1 2022 Apr 25, 2022	BUY	$55.72 - $67.12 $6,686 - $8,054	120 New	120 $8,000
Q2 2020 Aug 05, 2020	SELL	$43.1 - $55.31 $249,419 - $320,078	-5,787 Closed	0 $0
Q1 2020 Apr 13, 2020	BUY	$37.79 - $51.33 $218,690 - $297,046	5,787 New	5,787 $258,000

1,361

475M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $200B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Center Star Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Center Star Asset Management, LLC with notifications on news.